SpringWorks Therapeutics’ $300 Million Shares Private Placement

Goodwin Procter advised SpringWorks Therapeutics on the deal.SpringWorks Therapeutics, Inc. (Nasdaq: SWTX) announced its private placement transaction with a select group of institutional investors to issue and…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Martina Bellini

Author: Martina Bellini

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here